Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites

• Published in: The journal of clinical hypertension (Greenwich, Conn.) Conn.), 2024-04, Vol.26 (4), p.416-424
• Main Authors: Zhang, Weiyun, Li, Xiao, Li, Wanqin, Zhang, Yanmei, Cai, Jiajia, Feng, Shiyu, Sun, Zhaohui
• Format: Article
• Language: English
• Subjects: Abdomen; Antihypertensives; Biomarkers; Blood pressure; Body mass index; Catecholamines; catecholamines and their metabolites; Chromatography; Creatinine; Dopamine; Hypertension; Mass spectrometry; Metabolism; Metabolites; Original; paraganglioma; pheochromocytoma; Plasma; ROC curves; Scientific imaging; secondary hypertension; Tumors; UPLC‐MS/MS
• ISSN: 1524-6175; 1751-7176; 1751-7176
• DOI: 10.1111/jch.14779

This study aimed to elucidate the clinical diagnostic value of plasma catecholamines and their metabolites for pheochromocytoma and paraganglioma (PPGL)-induced secondary hypertension using ultraperformance liquid chromatography-mass spectrometry (UPLC-MS/MS). The study population included 155 patients with PPGL that were divided into the PPGL with hypertension (n = 79) and a PPGL without hypertension (n = 76) groups, and 90 healthy volunteers and 90 patients with primary hypertension as the control groups. UPLC-MS/MS was performed to detect plasma levels of catecholamines and their metabolites, including dopamine, vanillylmandelic acid (VMA), norepinephrine, metanephrine, and normetanephrine. Receiver operating characteristic curves were generated to analyze the diagnostic value of the plasma levels of catecholamines and their metabolites in PPGL-induced secondary hypertension. Patients in the primary hypertension and PPGL without hypertension groups had higher levels of dopamine, VMA, norepinephrine, metanephrine, and normetanephrine than patients in the normal group (all p